GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $834,000 | -57.3% | 13,200 | -65.5% | 0.01% | -61.1% |
| Q1 2020 | $1,954,000 | -41.8% | 38,237 | -9.5% | 0.02% | -21.7% |
| Q4 2019 | $3,358,000 | +55.0% | 42,237 | -5.4% | 0.02% | +76.9% |
| Q3 2019 | $2,166,000 | -5.2% | 44,637 | +2.8% | 0.01% | -18.8% |
| Q2 2019 | $2,285,000 | +172.0% | 43,437 | +173.5% | 0.02% | +166.7% |
| Q1 2019 | $840,000 | +24.1% | 15,883 | -3.6% | 0.01% | +20.0% |
| Q4 2018 | $677,000 | -2.2% | 16,483 | -9.4% | 0.01% | 0.0% |
| Q3 2018 | $692,000 | -2.5% | 18,200 | +15.9% | 0.01% | 0.0% |
| Q2 2018 | $710,000 | -2.6% | 15,700 | +4.0% | 0.01% | 0.0% |
| Q1 2018 | $729,000 | – | 15,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |